Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia

NCT04252131 is registered in ClinicalTrials.gov with Calo Psychiatric Center as lead sponsor.

NCT NCT04252131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04252131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia
Lead sponsor
Calo Psychiatric Center
Phase
Phase 1
Overall status
Completed
Start date
May 17, 2018
Completion date
October 31, 2019
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia